Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.
Steeb T, Wessely A, von Bubnoff D, Dirschka T, Drexler K, Falkenberg C, Hassel JC, Hayani K, Hüning S, Kähler KC, Karrer S, Krammer C, Leiter U, Lill D, Marsela E, Meiwes A, Nashan D, Nasifoglu S, Schmitz L, Sirokay J, Thiem A, Utikal J, Zink A, Berking C, Heppt MV. Steeb T, et al. Among authors: meiwes a. J Clin Med. 2020 May 12;9(5):1438. doi: 10.3390/jcm9051438. J Clin Med. 2020. PMID: 32408601 Free PMC article.
[Cutaneous squamous cell carcinoma].
Leiter U, Gutzmer R, Alter M, Ulrich C, Meiwes A, Heppt MV, Steeb T, Berking C, Lonsdorf AS, Sachse MM, Garbe C, Hillen U. Leiter U, et al. Among authors: meiwes a. Hautarzt. 2020 Aug;71(8):597-606. doi: 10.1007/s00105-020-04620-4. Hautarzt. 2020. PMID: 32583034 Review. German.
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.
Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, Hassel JC, Glutsch V, Sirokay J, Schlecht N, Rübben A, Gambichler T, Schatton K, Pfoehler C, Franklin C, Terheyden P, Haferkamp S, Mohr P, Bischof L, Livingstone E, Zimmer L, Weichenthal M, Schadendorf D, Meiwes A, Keim U, Garbe C, Becker JC, Ugurel S. Leiter U, et al. Among authors: meiwes a. J Immunother Cancer. 2020 Oct;8(2):e000897. doi: 10.1136/jitc-2020-000897. J Immunother Cancer. 2020. PMID: 33093156 Free PMC article.
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy.
Chatziioannou E, Leiter U, Thomas I, Keim U, Seeber O, Meiwes A, Boessenecker I, Gonzalez SS, Torres FM, Niessner H, Sinnberg T, Forschner A, Flatz L, Amaral T. Chatziioannou E, et al. Among authors: meiwes a. Am J Clin Dermatol. 2023 May;24(3):453-467. doi: 10.1007/s40257-023-00775-7. Epub 2023 May 4. Am J Clin Dermatol. 2023. PMID: 37142875 Free PMC article.
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.
Stefanou MI, Gepfner-Tuma I, Brendle C, Kowarik M, Meiwes A, Eigentler T, Müller A, Garbe C, Ziemann U, Tabatabai G, Forschner A. Stefanou MI, et al. Among authors: meiwes a. J Dtsch Dermatol Ges. 2020 Feb;18(2):136-139. doi: 10.1111/ddg.13991. Epub 2019 Dec 9. J Dtsch Dermatol Ges. 2020. PMID: 31814289 No abstract available.
Posteriores reversibles Enzephalopathie-Syndrom bei einem Melanompatienten unter Dabrafenib- und Trametinib-Behandlung nach Immuntherapie.
Stefanou MI, Gepfner-Tuma I, Brendle C, Kowarik M, Meiwes A, Eigentler T, Müller A, Garbe C, Ziemann U, Tabatabai G, Forschner A. Stefanou MI, et al. Among authors: meiwes a. J Dtsch Dermatol Ges. 2020 Feb;18(2):136-139. doi: 10.1111/ddg.13991_g. J Dtsch Dermatol Ges. 2020. PMID: 32026643 German. No abstract available.
15 results